Medimmune Sues Sun Pharma Over Plans For Ethyol Generic
Medimmune Oncology has sued Indian generic maker Sun Pharmaceuticals over its plans to make a generic version of the cancer-related drug Ethyol (amifostine)....To view the full article, register now.
Already a subscriber? Click here to view full article